These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8932444)

  • 21. Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran.
    Allison SD; Manning MC; Randolph TW; Middleton K; Davis A; Carpenter JF
    J Pharm Sci; 2000 Feb; 89(2):199-214. PubMed ID: 10688749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiol-disulfide exchange in peptides derived from human growth hormone during lyophilization and storage in the solid state.
    Chandrasekhar S; Topp EM
    J Pharm Sci; 2015 Apr; 104(4):1291-302. PubMed ID: 25631887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
    Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ
    J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved formulation and lyophilization cycle for rBCG vaccine.
    Jin TH; Nguyen L; Qu T; Tsao E
    Vaccine; 2011 Jun; 29(29-30):4848-52. PubMed ID: 21549782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
    Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
    Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-carotene encapsulation in a mannitol matrix as affected by divalent cations and phosphate anion.
    Sutter SC; Buera MP; Elizalde BE
    Int J Pharm; 2007 Mar; 332(1-2):45-54. PubMed ID: 17095170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temperature dependence of benzyl alcohol- and 8-anilinonaphthalene-1-sulfonate-induced aggregation of recombinant human interleukin-1 receptor antagonist.
    Roy S; Katayama D; Dong A; Kerwin BA; Randolph TW; Carpenter JF
    Biochemistry; 2006 Mar; 45(12):3898-911. PubMed ID: 16548517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of ribonuclease A in solution and the freeze-dried state.
    Townsend MW; DeLuca PP
    J Pharm Sci; 1990 Dec; 79(12):1083-6. PubMed ID: 2079655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing storage stability of lyophilized recombinant human interleukin-11 with disaccharide/hydroxyethyl starch mixtures.
    Garzon-Rodriguez W; Koval RL; Chongprasert S; Krishnan S; Randolph TW; Warne NW; Carpenter JF
    J Pharm Sci; 2004 Mar; 93(3):684-96. PubMed ID: 14762907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cryoprotectants on freezing, lyophilization, and storage of lyophilized recombinant alpha 1-antitrypsin formulations.
    Vemuri S; Yu CD; Roosdorp N
    PDA J Pharm Sci Technol; 1994; 48(5):241-6. PubMed ID: 8000898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
    Tang XC; Pikal MJ
    Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humidity induced collapse in freeze dried cakes: A direct visualization study using DVS.
    Duralliu A; Matejtschuk P; Williams DR
    Eur J Pharm Biopharm; 2018 Jun; 127():29-36. PubMed ID: 29408372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.
    Abdul-Fattah AM; Truong-Le V; Yee L; Nguyen L; Kalonia DS; Cicerone MT; Pikal MJ
    J Pharm Sci; 2007 Aug; 96(8):1983-2008. PubMed ID: 17286290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing the Formulation and Lyophilization Process for a Fragment Antigen Binding (Fab) Protein Using Solid-State Hydrogen-Deuterium Exchange Mass Spectrometry (ssHDX-MS).
    Kumar L; Chandrababu KB; Balakrishnan SM; Allmendinger A; Walters B; Zarraga IE; Chang DP; Nayak P; Topp EM
    Mol Pharm; 2019 Nov; 16(11):4485-4495. PubMed ID: 31568722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pH on stability of recombinant botulinum serotype A vaccine in aqueous solution and during storage of freeze-dried formulations.
    Roy S; Henderson I; Nayar R; Randolph TW; Carpenter JF
    J Pharm Sci; 2008 Dec; 97(12):5132-46. PubMed ID: 18399536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate.
    Clénet D; Hourquet V; Woinet B; Ponceblanc H; Vangelisti M
    Eur J Pharm Biopharm; 2019 Sep; 142():334-343. PubMed ID: 31306751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of PEG crystallization in frozen and freeze-dried PEGylated recombinant human growth hormone-sucrose systems: implications on storage stability.
    Bhatnagar BS; Martin SWH; Hodge TS; Das TK; Joseph L; Teagarden DL; Shalaev EY; Suryanarayanan R
    J Pharm Sci; 2011 Aug; 100(8):3062-3075. PubMed ID: 21491456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.